HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yaworsky, P. J. Articles by Kappen, C. Search for Related Content PubMed PubMed Citation Articles by Yaworsky, P. J. Articles by Kappen, C. Social Bookmarking                      What's this?

Volume 272, Number 40, Issue of October 3, 1997 pp. 25112-25120
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Transgenic Analyses Reveal Developmentally Regulated Neuron- and Muscle-specific Elements in the Murine Neurofilament Light Chain Gene Promoter

(Received for publication, December 18, 1996, and in revised form, June 13, 1997)

From the Samuel C. Johnson Medical Research Center, Mayo Clinic Arizona, Scottsdale, Arizona 85259

We report here the developmental activity of regulatory elements that reside within 1.7 kilobases of the murine neurofilament light chain (NF-L) gene promoter. NF-L promoter activity is first detected at embryonic day 8.5 in neuroepithelial cells. Neuron-specific gene expression is maintained in the spinal cord until embryonic day 12.5 and at later developmental stages in the brain and sensory neuroepithelia. After day 14.5, the promoter becomes active in myogenic cells. Transgene expression in both neurons and muscle is consistent with the detection of endogenous NF-L transcript in both neuronal and myogenic tissues of neonates by reverse transcriptase-polymerase chain reaction. Neuron- and muscle-specific activities of the NF-L promoter decrease and are nearly undetectable after birth. Thus, the 1.7-kilobase NF-L promoter contains regulatory elements for initiation but not maintenance of transcription from the NF-L locus. Deletion analyses reveal that independent regulatory elements control the observed tissue-specific activities and implicate a potential MyoD binding site as the muscle-specific enhancer. Our results demonstrate that the NF-L promoter contains distinct regulatory elements for both neuron- and muscle-specific gene expression and that these activities are temporally separated during embryogenesis.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. Komori, N. Takemori, H. K. Kim, A. Singh, S.-H. Hwang, R. D. Foreman, K. Chung, J. M. Chung, and H. Matsumoto Proteomics study of neuropathic and nonneuropathic dorsal root ganglia: altered protein regulation following segmental spinal nerve ligation injury Physiol Genomics, April 24, 2007; 29(2): 215 - 230. [Abstract] [Full Text] [PDF]

				V. M. Brown, A. Ossadtchi, A. H. Khan, S. Yee, G. Lacan, W. P. Melega, S. R. Cherry, R. M. Leahy, and D. J. Smith Multiplex Three-Dimensional Brain Gene Expression Mapping in a Mouse Model of Parkinson's Disease Genome Res., June 1, 2002; 12(6): 868 - 884. [Abstract] [Full Text] [PDF]

				F. Naya, C Wu, J. Richardson, P Overbeek, and E. Olson Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene Development, January 5, 1999; 126(10): 2045 - 2052. [Abstract] [PDF]

				K. Borges and R. Dingledine Functional Organization of the GluR1 Glutamate Receptor Promoter J. Biol. Chem., July 6, 2001; 276(28): 25929 - 25938. [Abstract] [Full Text] [PDF]